LifeLabs is committed to supporting our communities across Canada and providing a safe environment for our employees and customers at all times, including during the COVID-19 pandemic. We are working to put measures in place to limit the impacts to our customers, however there is a possibility that turnaround times may ...

TORONTO, ON. [December 17, 2019] – LifeLabs is releasing the below open letter to its customers in Canada, following a recent cyber security-attack. To our customers: Through proactive surveillance, LifeLabs recently identified a cyber-attack that involved unauthorized access to our computer systems with customer information that could include name, address, ...

LifeLabs Genetics is proud to announce the expansion of our molecular diagnostic testing capabilities. As a result of feedback from healthcare providers across the country who want access to Canadian genetic testing options, we are now offering testing for inherited conditions, using next-generation sequencing, from our lab in Surrey, British ...

Tuberous sclerosis complex is a genetic disorder characterized by the growth of numerous benign tumors in vital organs, such as skin, brain, kidneys among others. Common clinical indications of TSC include, but are not limited to: Skin Patches of white- or light-coloured skin (Hypomelanotic macules) Oval-shaped skin lesions (Shagreen ...